Literature DB >> 11384877

Regulation of steroidogenic enzymes and a novel testicular RNA helicase.

M L Dufau1, C Tsai-Morris, P Tang, A Khanum.   

Abstract

Luteinizing hormone (LH) supports steroidogenesis and maintains testicular and ovarian function. Mediators of LH action exert homologous regulation of membrane receptors, steroidogenic enzymes and other regulatable genes of the Leydig cell (LC). Androgen and estrogen induced by LH could act through its cognate receptors in the LC to regulate gene expression. Although androgens are unquestionable essential for spermatogenesis and presumably exert their heterologous action through androgen receptors present in the Sertoli its regulatory mechanism in germinal cell maturation is far from clear. In contrast to physiological concentrations of gonadotropins which maintain the steroidogenic functions and LH and prolactin receptors in the gonads, high concentrations of gonadotropin (hCG) cause receptor down-regulation and desensitization of steroidogenic enzymes of the LCs in vivo (3beta-hydroxysteroid dehydrogenase types I and II, 17alpha-hydroxylase/17,20 lyase, and 17beta-hydroxysteroid dehydrogenase type III [17beta-HSD]). In addition, 17beta-HSD is regulated by compartmentalized endogenous glucose/ATP. The attenuation of steroidogenesis which results from receptor mediated activation by cognate hormone, but is independent of the subsequent phase of receptor down-regulation, is due to changes at the transcriptional level. Among the candidates affecting this regulation are active steroid metabolites (direct or indirect of steroids and other mediator(s) i.e. cAMP, putative transcription factors induced by LH action). Differential display assay revealed another gene which is transcriptionally regulated by gonadotropin termed GRTH (Gonadotropin Regulated Testicular Helicase). GRTH is a novel member of the DEAD-box family of RNA helicases, and is specifically expressed in LCs and meiotic LC of the testis. It is markedly up-regulated by hCG via cAMP-induced androgen formation in LCs at doses that cause down-regulation of receptors and steroidogenic enzymes. GRTH functions as a translational activator. Androgen produced by gonadotropin stimulation exerts intracrine/autocrine actions on GRTH, and also could influence transcription within the seminiferous tubule. GRTH may contribute to the control of steroidogenesis, including the restoration of down regulated cellular functions, and in the paracrine regulation of androgen dependent gene(s) involved in the meiotic process, and could thus have a crucial role in spermatogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384877     DOI: 10.1016/s0960-0760(01)00051-6

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  3 in total

1.  The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification.

Authors:  Martin B Lee; Lioudmila A Lebedeva; Miyuki Suzawa; Subhagya A Wadekar; Marion Desclozeaux; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

2.  A new analysis of testicular proteins through integrative bioinformatics.

Authors:  Liu Fu-Jun; Wang Hai-Yan; Li Jian-Yuan
Journal:  Mol Biol Rep       Date:  2011-07-16       Impact factor: 2.316

3.  Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.

Authors:  Rona J Strawbridge; Josée Dupuis; Inga Prokopenko; Adam Barker; Emma Ahlqvist; Denis Rybin; John R Petrie; Mary E Travers; Nabila Bouatia-Naji; Antigone S Dimas; Alexandra Nica; Eleanor Wheeler; Han Chen; Benjamin F Voight; Jalal Taneera; Stavroula Kanoni; John F Peden; Fabiola Turrini; Stefan Gustafsson; Carina Zabena; Peter Almgren; David J P Barker; Daniel Barnes; Elaine M Dennison; Johan G Eriksson; Per Eriksson; Elodie Eury; Lasse Folkersen; Caroline S Fox; Timothy M Frayling; Anuj Goel; Harvest F Gu; Momoko Horikoshi; Bo Isomaa; Anne U Jackson; Karen A Jameson; Eero Kajantie; Julie Kerr-Conte; Teemu Kuulasmaa; Johanna Kuusisto; Ruth J F Loos; Jian'an Luan; Konstantinos Makrilakis; Alisa K Manning; María Teresa Martínez-Larrad; Narisu Narisu; Maria Nastase Mannila; John Ohrvik; Clive Osmond; Laura Pascoe; Felicity Payne; Avan A Sayer; Bengt Sennblad; Angela Silveira; Alena Stancáková; Kathy Stirrups; Amy J Swift; Ann-Christine Syvänen; Tiinamaija Tuomi; Ferdinand M van 't Hooft; Mark Walker; Michael N Weedon; Weijia Xie; Björn Zethelius; Halit Ongen; Anders Mälarstig; Jemma C Hopewell; Danish Saleheen; John Chambers; Sarah Parish; John Danesh; Jaspal Kooner; Claes-Göran Ostenson; Lars Lind; Cyrus C Cooper; Manuel Serrano-Ríos; Ele Ferrannini; Tom J Forsen; Robert Clarke; Maria Grazia Franzosi; Udo Seedorf; Hugh Watkins; Philippe Froguel; Paul Johnson; Panos Deloukas; Francis S Collins; Markku Laakso; Emmanouil T Dermitzakis; Michael Boehnke; Mark I McCarthy; Nicholas J Wareham; Leif Groop; François Pattou; Anna L Gloyn; George V Dedoussis; Valeriya Lyssenko; James B Meigs; Inês Barroso; Richard M Watanabe; Erik Ingelsson; Claudia Langenberg; Anders Hamsten; Jose C Florez
Journal:  Diabetes       Date:  2011-08-26       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.